EUVIMEDEUVIMED entdecken
Open Access

Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities

Hui-Hsuan Kuo iD, Bhavneet Bhinder iD, Hamza N Gokozan iD, Kathryn Gorski, Pooja Chandra, Jyothi Manohar iD, Daniela Guevara iD, John Otilano, Jenna Moyer, Marvel Tranquille iD, Sarah Ackermann iD, Jared Capuano und 48 weitere

Science Advances · 26.06.2026 · 12 (26)

DOI: 10.1126/sciadv.adz3351 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Science Advances, erschienen am 26.06.2026. Verfasst von Hui-Hsuan Kuo und 59 weiteren Autor:innen. Beteiligte Einrichtung: Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10021, USA. Hauptthemen laut MEDLINE: Neoplasms, Organoids, Genetic Heterogeneity. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 94 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Institute, National Institute of Arthritis and Musculoskeletal and Skin Diseases, DOD Prostate Cancer Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We developed a pan-cancer patient-derived organoid (PDO) platform comprising 220 PDOs from 191 patients across 15 cancer types to advance functional precision oncology. Comprehensive characterization demonstrated high fidelity to parent tumors, with 93% histopathology concordance, 80% median genomic concordance for driver mutations, and a 0.85 median gene expression correlation. Expression profiles remained largely stable over 10 passages, ensuring reproducibility for long-term screening. Clonality analysis showed that 85% of dominant tumor clones were preserved, with genomic concordance directly reflecting clonal similarity. Even PDOs with lower concordance retained key oncogenic drivers, validating their utility as disease models. Functional assays revealed that 58% of PDOs from patients ineligible for US Food and Drug Administration–approved poly(adenosine 5′-diphosphate–ribose) polymerase inhibitors were sensitive to talazoparib, linked to DNA damage repair alterations. Furthermore, combination screens identified agents that overcome resistance, particularly in TP53 -mutant models. Our platform enables the investigation of targeted therapies and molecular drivers of drug sensitivity, providing translational insights for personalized treatment beyond current biomarker guidelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsOrganoidsGenetic HeterogeneityHumansMutationPrecision MedicineGene Expression Regulation, NeoplasticAntineoplastic AgentsPoly(ADP-ribose) Polymerase InhibitorsPhthalazinesDrug Resistance, Neoplasm

Substanzen

Antineoplastic AgentsPoly(ADP-ribose) Polymerase InhibitorstalazoparibPhthalazines

Autor:innen und Institutionen

  • Englander Institute for Precision Medicine, Weill Cornell Medicine, New York, NY 10021, USA.
  • Institute for Computational Biomedicine, Weill Cornell Medicine, New York, NY 10021, USA.
  • Department of Pathology and Laboratory Medicine, Weill Cornell Medicine, New York, NY USA 10065.
  • Department of Urology, Weill Cornell Medicine, New York, NY 10065 USA.
  • Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, NY 10065 USA.
  • Department of Obstetrics and Gynecology, Weill Cornell Medicine, New York, NY 10065, USA.

ORCID-Profile: Hui-Hsuan Kuo, Bhavneet Bhinder, Hamza N Gokozan, Jyothi Manohar, Daniela Guevara, Marvel Tranquille, Sarah Ackermann, Cynthia Cheung, Thomas A Caiazza, Phoebe L Reuben, Anastasia Murray Tsomides, Adriana Irizarry, Michael Sigouros, David Wilkes, Troy Kane, Majd Al Assaad, Wael Al Zoughbi, Joonghoon Auh, Peter Waltman, Florencia P Madorsky Rowdo, Valerie Gallegos, John Nguyen, Raehash Shah, Manish Shah, Allyson Ocean, Douglas Scherr, Nasser Altorki, Melissa Frey, Ana M Molina, Lisa Newman, Eloise Chapman-Davis, Marcus D Goncalves, Parul J Shukla, Scott Tagawa, Jonathan H Zippin, Rohit Chandwani, Kelly Garrett, Pashtoon M Kasi, Jones T Nauseef, Momin T Siddiqui, Alicia Alonso, Cora N Sternberg, Bishoy M Faltas

Förderung

  • National Cancer Institute
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • DOD Prostate Cancer Research Program
  • Manoogian Simone Foundation
  • 2020 AACR-The Mark Foundation for Cancer Research “Science of the Patient” Grants

Zitieren

APA

Kuo, H. H., Bhinder, B., Gokozan, H. N., Gorski, K., Chandra, P., Manohar, J., Guevara, D., Otilano, J., Moyer, J., Tranquille, M., Ackermann, S., Capuano, J., Cheung, C., Caiazza, T. A., Reuben, P. L., Tsomides, A. M., Irizarry, A., Sigouros, M., Wilkes, D., …, & Faltas, B. M. (2026). Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities. Science Advances, 12(26). https://doi.org/10.1126/sciadv.adz3351

Vancouver

Kuo HH, Bhinder B, Gokozan HN, Gorski K, Chandra P, Manohar J, et al. Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities. Science Advances. 2026;12(26). doi:10.1126/sciadv.adz3351

BibTeX
@article{Kuo2026,
  author = {Kuo, Hui-Hsuan and Bhinder, Bhavneet and Gokozan, Hamza N and Gorski, Kathryn and Chandra, Pooja and Manohar, Jyothi and Guevara, Daniela and Otilano, John and Moyer, Jenna and Tranquille, Marvel and Ackermann, Sarah and Capuano, Jared and Cheung, Cynthia and Caiazza, Thomas A and Reuben, Phoebe L and Tsomides, Anastasia Murray and Irizarry, Adriana and Sigouros, Michael and Wilkes, David and King, Abigail and Kane, Troy and Al Assaad, Majd and Al Zoughbi, Wael and Ohara, Kentaro and Auh, Joonghoon and Waltman, Peter and Madorsky Rowdo, Florencia P and Podaza, Enrique and Gallegos, Valerie and Nguyen, John and Shah, Raehash and Shah, Manish and Ocean, Allyson and Scherr, Douglas and Altorki, Nasser and Frey, Melissa and Molina, Ana M and Newman, Lisa and Bea, Vivan and Chapman-Davis, Eloise and Goncalves, Marcus D and Saxena, Ashish and Shukla, Parul J and Holcomb, Kevin and Simmons, Rachel and Tagawa, Scott and Zippin, Jonathan H and Cantillo, Evelyn and Chandwani, Rohit and Davis, Melissa and Garrett, Kelly and Kasi, Pashtoon M and Marti, Jennifer and Nanus, David and Nauseef, Jones T and Popa, Elizabeth and Siddiqui, Momin T and Alonso, Alicia and Sternberg, Cora N and Faltas, Bishoy M},
  title = {Patient-derived organoids across cancers reveal conserved tumor heterogeneity and actionable therapeutic vulnerabilities},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {26},
  doi = {10.1126/sciadv.adz3351}
}
Kostenlos starten →